PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Randox Laboratories Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Randox Laboratories Ltd Introduces New Multiple Cardiac Tests - Randox Laboratories Ltd have launched a revolutionary new Biochip Analyser that will save cardiac patients lives by providing immediate diagnosis at the point of care
Randox Laboratories Ltd Introduces New Multiple Cardiac Tests

 

NewswireToday - /newswire/ - Crumlin, Antrim, United Kingdom, 2009/10/12 - Randox Laboratories Ltd have launched a revolutionary new Biochip Analyser that will save cardiac patients lives by providing immediate diagnosis at the point of care.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Cardiovascular disease is a progressive and complicated condition, covering a spectrum of symptoms and biochemical processes which are different in many patients. Multiple markers are therefore required to provide an accurate diagnosis but it is essential this is available rapidly in the A&E department.

The Randox Evidence MultiStat is a revolutionary new desktop analyser which offers up to 8 cardiac results within just 20 minutes. This innovative new technology ensures the accuracy and precision of a commercial laboratory analyser within the A & E department delivering significant benefits for those patients with chest pains by rapidly identifying risk and enabling accurate clinical decisions.

With some blood biomarkers only detectable for 6 hours after a heart attack, patients presenting with early symptoms are often missed. The Evidence MultiStat will ultimately save patient lives by giving accurate and timely diagnosis when time is at a premium.

The Evidence MultiStat is based upon the award winning Biochip technology from Randox and utilises the precision and accuracy of the commercially available lab based Evidence analyser giving the Evidence MultiStat distinct advantages over other lower quality rapid devices currently in the market.

The Evidence MultiStat also offers an array for drugs of abuse with arrays for stroke, metabolic syndrome, cancer, fertility disorders, thyroid disorders, synthetic steroids and additional drugs of abuse currently in development. The system is suitable for a variety of point of patient environments including emergency departments, cardiac units, doctor surgeries, forensic units, rehab units and employee drug screening centres. The technology offers fully automated pipetting, incubation, washing, imaging and report generation ensuring that the MultiStat can be used by non technical staff. User friendly touch screen Windows ® based software also ensures little or no training is required.

Randox have developed a comprehensive test menu that can work with a wide range of sample matrix including urine and serum with plasma and whole blood currently in development. The Cardiac Arrays includes CK-MB, FABP, Myoglobin and Cardiac Troponin with the Drugs of Abuse Array includes multiple analytes such as Amphetamine, Barbiturates, Benzadiazepine, Cannabinoids and Cocaine.

About Randox
Randox (randox.com) is an international diagnostics company, headquartered in the UK. Randox develop, manufacture and market clinical diagnostic products worldwide. Core products are: Biochip Array Technology; clinical chemistry analysers and reagents; quality controls and EQA; recombinant proteins and antibodies.

About Biochip Technology
The evidence MutiStat comes from a family of immunoassay analysers, all of which offer flexibility, quality and reliability. The largest member of the family is the Evidence with an output of 1,400 tests per hour.

Randox was the world’s first protein biochip manufacturer. The technology is based on the concept of using a biochip as a reaction platform with multiple specific ligands (antibodies and antigens) attached at pre-defined sites on the surface.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Randox Laboratories Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Randox Laboratories Ltd Introduces New Multiple Cardiac Tests

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Charlotte Jess - Randox.com 
+44(0)28 4245 7832 charlotte.jess[.]randox.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Randox Laboratories Ltd securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Randox Laboratories Ltd / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Frost & Sullivan Lauds SnooZeal’s Unique Electrical Stimulation Therapy for Sleep Apnea in the European Market
ZOLL Expands the Rescuer Experience at EMS Today
Traditional Mass Spectrometers Give Way to High-resolution Technologies Such as MALDI-TOF Finds Frost & Sullivan
AccuVein, Inc. Named A Best Place to Work in Medical Sales for Second Consecutive Year
MRI Inventor to Receive the Medtech Innovation Catalyst Award
Ansell Limited Acquires Cleanroom and Healthcare Consumables Manufacturer Nitritex Limited
ZOLL to Showcase Expanded Portfolio of Advanced Resuscitation and Acute Critical Care Technologies at Arab Health 2017
Frost & Sullivan Awards Ansell for Entrenching itself in the Hand Protection Market with its Visionary Products and Technologies
ZOLL RescueNet ePCR Achieves Latest National Compliance Standard
Eye Tech Care Wins Top Honours from Frost & Sullivan for Developing the EyeOP1, the Only Computer-assisted System for Glaucoma Therapy
Frost & Sullivan Recognizes Nuvectra’s Pioneering Spinal Cord Stimulation Product for Chronic Pain Management
GE Healthcare to Commercialize Rapiscan® Outside the US, Canada & Mexico for Increased Access to Heart Exams
Novel Home Care Needs and Customer Preferences Catalyse Growth Opportunities in Mature Cardiac Monitoring Market Finds Frost & Sullivan
Frost & Sullivan Highlights Inspirata's Leading-edge Digital Pathology Solutions that Accelerate Cancer Diagnostics, Monitoring, Treatment
Sparta Systems Broadens Partnership with TrackWise Implementation Specialist Equality Systems

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)